Rankings
▼
Calendar
EDIT Q2 2024 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena
EDIT
Editas Medicine, Inc.
$256M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$513,000
-82.2% YoY
Gross Profit
-$907,000
-176.8% margin
Operating Income
-$72M
-14016.2% margin
Net Income
-$68M
-13178.8% margin
EPS (Diluted)
$-0.82
QoQ Revenue Growth
-54.8%
Cash Flow
Operating Cash Flow
-$57M
Free Cash Flow
-$61M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$385M
Total Liabilities
$153M
Stockholders' Equity
$232M
Cash & Equivalents
$64M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$513,000
$3M
-82.2%
Gross Profit
-$907,000
-$27M
+96.6%
Operating Income
-$72M
-$44M
-63.1%
Net Income
-$68M
-$40M
-67.8%
← FY 2024
All Quarters
Q3 2024 →